G. Landucci

发表

HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study

C. Katlama, Johannes S. Gach, C. Achenbach, 2014, PloS one.

Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

Vicki C. Ashley, Leslie L. Chavez, Allan C. deCamp, 2008, Journal of Virology.

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

Jerome H. Kim, B. Korber, H. Liao, 2015, PLoS pathogens.

Neutralizing Polyclonal IgG Present during Acute Infection Prevents Rapid Disease Onset in Simian-Human Immunodeficiency Virus SHIVSF162P3-Infected Infant Rhesus Macaques

N. Haigwood, D. Burton, A. Legasse, 2013, Journal of Virology.

Title Neutralizing Polyclonal IgG Present during Acute Infection Prevents Rapid Disease Onset in Simian-Human Immunodeficiency Virus SHIV SF 162 P 3-Infected Infant Rhesus Macaques Permalink

D. Burton, A. Legasse, M. Axthelm, 2013 .

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines

Pojen P. Chen, H. Liao, J. Kappes, 2010, The Journal of experimental medicine.

Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys

D. Montefiori, K. Mansfield, G. Landucci, 2008, Nature.

The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells

D. Burton, L. Ping, A. Lanzavecchia, 2013, PLoS pathogens.

Measles virus-specific functional antibody responses and viremia during acute measles.

G. Landucci, D. Forthal, A. Habis, 1994, The Journal of infectious diseases.

Rapid High-Level Production of Functional HIV Broadly Neutralizing Monoclonal Antibodies in Transient Plant Expression Systems

D. Montefiori, R. Fischer, G. Landucci, 2013, PloS one.

Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine.

G. Landucci, D. Forthal, T. Ross, 2012, AIDS research and human retroviruses.

Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal

W. Heneine, D. Montefiori, K. Abel, 2012, Retrovirology.

Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

S. Self, D. Montefiori, K. Mansfield, 2009, Journal of Virology.

Chemically Modified Peptides Based on the Membrane-Proximal External Region of the HIV-1 Envelope Induce High-Titer, Epitope-Specific Nonneutralizing Antibodies in Rabbits

J. Levy, V. Venditto, F. Szoka, 2014, Clinical and Vaccine Immunology.

Activity of Monoclonal Antibody 2G12 Binding and Cell-Mediated Anti-HIV Receptor γ Fc-Glycosylation Influences Fc

Johannes S. Gach, G. Landucci, D. Forthal, 2017 .

Fc-Glycosylation Influences Fcγ Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12

Johannes S. Gach, G. Landucci, D. Forthal, 2010, The Journal of Immunology.

Interactions between Natural Killer Cells and Antibody Fc Result in Enhanced Antibody Neutralization of Human Immunodeficiency Virus Type 1

G. Landucci, D. Forthal, J. Becerra, 2005, Journal of Virology.

FcγRIIa Genotype Predicts Progression of HIV Infection1

G. Landucci, D. Forthal, L. Jacobson, 2007, The Journal of Immunology.

CD8+ T-cell mediated tumor protection by Pseudomonas exotoxin fused to ovalbumin in C57BL/6 mice.

G. Landucci, D. Forthal, C. Theuer, 2003, Surgery.

Sex-Associated Differences in the Antibody-Dependent Cellular Cytotoxicity Antibody Response to Measles Vaccines

H. Whittle, S. Atabani, G. Landucci, 2000, Clinical Diagnostic Laboratory Immunology.

FcgammaRIIa genotype predicts progression of HIV infection.

G. Landucci, D. Forthal, L. Jacobson, 2007, Journal of immunology.

HIV Infection Rate Effector Cells and Correlate Inversely with in the Presence of Fc Receptor-Bearing Antibodies Inhibit Clinical Strains of HIV-1 Recombinant gp 120 Vaccine-Induced

P. Gilbert, G. Landucci, D. Forthal, 2007 .

Proceedings of the Frontiers of Retrovirology Conference 2016

R. König, D. Elleder, R. Sachidanandam, 2016, Retrovirology.

Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions.

G. Landucci, D. Forthal, J. Katz, 1993, The Journal of infectious diseases.

Rhesus Macaque Polyclonal and Monoclonal Antibodies Inhibit Simian Immunodeficiency Virus in the Presence of Human or Autologous Rhesus Effector Cells

G. Landucci, D. Forthal, K. V. Van Rompay, 2006, Journal of Virology.

Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells

E. Daar, G. Landucci, D. Forthal, 2001, Journal of Virology.

Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count.

G. Landucci, D. Forthal, B. Keenan, 2001, AIDS research and human retroviruses.

Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients.

R. Haubrich, G. Landucci, D. Forthal, 1999, The Journal of infectious diseases.

Antibody-Dependent Cellular Cytotoxicity Independently Predicts Survival in Severely Immunocompromised Human Immunodeﬁciency Virus–Infected Patients

R. Haubrich, G. Landucci, D. Forthal, 1999 .

Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

N. Haigwood, D. Burton, B. Richardson, 2010, Nature Medicine.

Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

D. Burton, D. Watkins, W. Koff, 2009, Journal of Virology.

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers

D. Burton, D. Watkins, W. Koff, 2009, PLoS pathogens.

Fc receptor but not complement binding is important in antibody protection against HIV

D. Burton, P. Parren, P. Marx, 2007, Nature.

Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses

J. Overbaugh, Xueling Wu, G. Landucci, 2008, Virology Journal.

Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.

R. McClelland, B. Chohan, C. Blish, 2013, Journal of acquired immune deficiency syndromes.

In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity.

G. Landucci, D. Forthal, 1998, Journal of immunological methods.

Predominance of Detrimental Humoral Immune Responses to HIV‐1 in AIDS Patients with CD4 Lymphocyte Counts Less Than 400/mm3

G. Landucci, D. Forthal, B. McDougall, 1997, Scandinavian journal of immunology.

A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques

S. Iida, D. Burton, P. Parren, 2012, Journal of Virology.

1 Monoclonal Antibody b 12 Has Enhanced Fc ? RIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques Permalink

P. Parren, D. Watkins, J. Schmitz, 2012 .

Title Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV : outcome depends on IgG dose Permalink

D. Montefiori, H. Ertl, M. Robert-Guroff, 2014 .

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose

D. Montefiori, H. Ertl, M. Robert-Guroff, 2014, Retrovirology.

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

Karen G. Dowell, J. C. Love, J. Kappes, 2016, The Journal of Immunology.

Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques.

D. Montefiori, D. Venzon, J. Héraud, 2011, Vaccine.

Evaluation of Passively Transferred, Nonneutralizing Antibody-Dependent Cellular Cytotoxicity-Mediating IgG in Protection of Neonatal Rhesus Macaques against Oral SIVmac251 Challenge1

N. Haigwood, D. Venzon, M. Robert-Guroff, 2006, The Journal of Immunology.

Challenge mac251 against Oral SIV Protection of Neonatal Rhesus Macaques Cellular Cytotoxicity-Mediating IgG in Nonneutralizing Antibody-Dependent Evaluation of Passively Transferred,

Marjorie, Madhumita, N. Haigwood, 2006 .

Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.

S. Reddy, N. Kurihara, J. Windle, 2001, Endocrinology.

Antibody inhibition of cytomegalovirus: the role of natural killer and macrophage effector cells

T. Phan, G. Landucci, D. Forthal, 2001, Transplant infectious disease : an official journal of the Transplantation Society.

Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination.

G. Landucci, D. Forthal, E. Gabriel, 2012, Blood.

IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation

H. Ding, J. Kappes, G. Landucci, 2011, AIDS.

Recombinant gp120 Vaccine-Induced Antibodies Inhibit Clinical Strains of HIV-1 in the Presence of Fc Receptor-Bearing Effector Cells and Correlate Inversely with HIV Infection Rate1

P. Gilbert, G. Landucci, D. Forthal, 2007, The Journal of Immunology.

Functional activities of 20 human immunodeficiency virus type 1 (HIV-1)-specific human monoclonal antibodies.

S. Zolla-Pazner, M. Gorny, G. Landucci, 1995, AIDS research and human retroviruses.

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens

S. Self, D. Montefiori, R. Gottardo, 2016, Journal of Virology.

Streamlining Heterologous DNA-Prime and NYVAC / Protein-Boost HIV Vaccine Regimens in 1 Rhesus Macaques by Employing Improved Antigens 2 3

S. Self, D. Montefiori, R. Gottardo, 2016 .

Title Employing Improved Antigens Allows Streamlining of Heterologous DNA-Prime and NYVAC / Protein-Boost HIV Vaccine Regimens in Rhesus Macaques Running title : Improved HIV Antigens and Delivery Schedules in Macaques

Ralf, Barnett, D. Montefiori, 2015 .

Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein

S. Kalams, J. Crowe, Amanda S. Joyner, 2015, PloS one.

Title Association of VH 4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein Permalink

Paul, S. Kalams, J. Crowe, 2015 .

Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11

G. Landucci, D. Forthal, K. V. Van Rompay, 2006, Virology Journal.

Proceedings of the Frontiers of Retrovirology Conference 2016

Sebastian A. Wagner, R. König, D. Elleder, 2016, Retrovirology.

Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques.

D. Montefiori, D. Venzon, J. Héraud, 2011, Vaccine.

The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells

D. Burton, A. Lanzavecchia, Johannes S. Gach, 2013, PLoS pathogens.

Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations.

S. Kalams, J. Crowe, G. Landucci, 2016, Molecular immunology.

Lymphokine‐Activated Cytotoxicity in Peripheral Blood Mononuclear Cells of Severely Immunocompromised HIV‐Infected Patients

G. Landucci, D. Forthal, W. ROBINSON JR., 1997, Scandinavian journal of immunology.

Anti-Viral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein Against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models

S. Prakash, Ruchi Srivastava, H. Vahed, 2023, bioRxiv.